InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2024-05-13 00:00:00 ET · period of report 2024-05-13 · accession 0001055726-24-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-13 2024-05-13 INO DANSEY ROGER D Dir M - OptEx — +1,000 4,583 +28% —
D 2024-05-13 2024-05-13 INO DANSEY ROGER D Dir M - OptEx $0.00 -1,000 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-13 M A 1,000 — 4,583 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 3,000 restricted stock units was as follows: 1,000 shares vested on May 13, 2022; 1,000 shares vested on May 13, 2023; and 1,000 shares vested on May 13, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
2 Derivative Restricted Stock Unit 2024-05-13 M D 1,000 $0.00 0 D — · — to — 1,000 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 3,000 restricted stock units was as follows: 1,000 shares vested on May 13, 2022; 1,000 shares vested on May 13, 2023; and 1,000 shares vested on May 13, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.